AI assistant
Prudential PLC — Share Issue/Capital Change 2020
Mar 20, 2020
4668_rns_2020-03-20_3415e5f0-a93e-4ac0-ac80-ca43bb2847c9.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9790G
Prudential PLC
20 March 2020
Prudential plc
--------------------
Application has been made to the Financial Conduct Authority and the London Stock Exchange Plc for a total of 8,000,000 ordinary shares of 5 pence each ("Shares") to be admitted to the Official List.
These shares are being reserved under a block listing and will be issued as a result of the vesting of discretionary awards pursuant to the following schemes:
| Schemes | Shares |
| Prudential Long Term Incentive Plan | 5,500,000 |
| Prudential Agency Long Term Incentive Plan | 2,500,000 |
The admission date for these shares is expected to be Monday 23 March 2020. When issued, these shares will rank pari passu with the existing ordinary shares.
The shares to be issued under the Prudential Long Term Incentive Plan and the Prudential Agency Long Term Incentive Plan will be under the Company's authority to allot ordinary shares approved at its annual general meeting in 2019.
Name of contact and telephone number for queries
Jennie Webb, Share Plans and Share Capital Manager, +44 (0)20 3977 9750
Name of duly authorised officer of issuer responsible for making notification
Chris Smith, Deputy Group Secretary, +44 (0)20 3977 9639
Date of notification
20 March 2020
Prudential plc is not affiliated in any manner with Prudential Financial, Inc., a company whose principal place of business is in the United States of America nor with the Prudential Assurance Company, a subsidiary of M&G plc, a company incorporated in the United Kingdom.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
ALSKKKBPFBKKNNB